EN PL

GMP: EMA issues Draft Guideline on Process Validation for Biotechnological Products - an Analysis

15.05.2014
The draft on process validation for biotechnologically manufactured active pharmaceutical ingredients describes the required data to be submitted for the marketing authorisation or variation of biotechnology-derived proteins used as active substance in the manufacture of medicinal products.